Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) FCF Margin (2016 - 2025)

Historic FCF Margin for Abeona Therapeutics (ABEO) over the last 13 years, with Q2 2025 value amounting to 5421.25%.

  • Abeona Therapeutics' FCF Margin changed N/A to 5421.25% in Q2 2025 from the same period last year, while for Sep 2025 it was 20590.0%, marking a year-over-year change of. This contributed to the annual value of 1066.86% for FY2023, which is 20175100.0% up from last year.
  • Abeona Therapeutics' FCF Margin amounted to 5421.25% in Q2 2025.
  • Abeona Therapeutics' 5-year FCF Margin high stood at 69802.08% for Q4 2021, and its period low was 20613.24% during Q4 2022.
  • For the 4-year period, Abeona Therapeutics' FCF Margin averaged around 4659.1%, with its median value being 294.74% (2023).
  • Its FCF Margin has fluctuated over the past 5 years, first skyrocketed by 698568500bps in 2021, then plummeted by -904153200bps in 2022.
  • Abeona Therapeutics' FCF Margin (Quarter) stood at 69802.08% in 2021, then plummeted by -130bps to 20613.24% in 2022, then soared by 99bps to 294.74% in 2023, then plummeted by -1739bps to 5421.25% in 2025.
  • Its last three reported values are 5421.25% in Q2 2025, 294.74% for Q2 2023, and 20613.24% during Q4 2022.